EUVIMEDEUVIMED entdecken
Crossref

A narrative review on palbociclib for hormone receptor-positive and human epidermal growth factor receptor-2 negative advanced breast cancer

AnShun Zhang, JiangXia Yin, ChangMing Song

Cancer Advances · 2022

DOI: 10.53388/2022522011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Advances, 2022. Verfasst von AnShun Zhang und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhang, A., Yin, J., & Song, C. (2022). A narrative review on palbociclib for hormone receptor-positive and human epidermal growth factor receptor-2 negative advanced breast cancer. Cancer Advances. https://doi.org/10.53388/2022522011

Vancouver

Zhang A, Yin J, Song C. A narrative review on palbociclib for hormone receptor-positive and human epidermal growth factor receptor-2 negative advanced breast cancer. Cancer Advances. 2022. doi:10.53388/2022522011

BibTeX
@article{Zhang2022,
  author = {Zhang, AnShun and Yin, JiangXia and Song, ChangMing},
  title = {A narrative review on palbociclib for hormone receptor-positive and human epidermal growth factor receptor-2 negative advanced breast cancer},
  journal = {Cancer Advances},
  year = {2022},
  doi = {10.53388/2022522011}
}
Kostenlos starten →